Anne Victoria Grossestreuer, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Arrest | 41 | 2024 | 1516 | 4.900 |
Why?
|
Hypothermia, Induced | 22 | 2021 | 752 | 3.730 |
Why?
|
Cardiopulmonary Resuscitation | 37 | 2024 | 1002 | 3.060 |
Why?
|
Out-of-Hospital Cardiac Arrest | 17 | 2024 | 340 | 2.020 |
Why?
|
Thiamine | 12 | 2024 | 160 | 1.650 |
Why?
|
Body Temperature | 5 | 2021 | 779 | 0.870 |
Why?
|
Diabetic Ketoacidosis | 2 | 2024 | 253 | 0.850 |
Why?
|
Shock, Septic | 8 | 2024 | 774 | 0.850 |
Why?
|
Lactic Acid | 9 | 2024 | 1137 | 0.710 |
Why?
|
Registries | 18 | 2022 | 8297 | 0.680 |
Why?
|
Coma | 4 | 2017 | 485 | 0.640 |
Why?
|
Pancreatitis | 1 | 2024 | 1087 | 0.550 |
Why?
|
Ascorbic Acid | 4 | 2021 | 657 | 0.540 |
Why?
|
Hypoxia, Brain | 1 | 2016 | 139 | 0.500 |
Why?
|
Life Support Care | 1 | 2016 | 226 | 0.480 |
Why?
|
Acute Kidney Injury | 2 | 2023 | 1946 | 0.450 |
Why?
|
Hospital Mortality | 15 | 2022 | 5343 | 0.450 |
Why?
|
Nervous System | 1 | 2016 | 542 | 0.420 |
Why?
|
Hyperthermia, Induced | 1 | 2016 | 415 | 0.410 |
Why?
|
Sepsis | 6 | 2024 | 2606 | 0.400 |
Why?
|
Respiration, Artificial | 8 | 2023 | 2709 | 0.400 |
Why?
|
Withholding Treatment | 1 | 2016 | 621 | 0.390 |
Why?
|
Hot Temperature | 1 | 2018 | 1433 | 0.390 |
Why?
|
Oxygen Consumption | 5 | 2024 | 1870 | 0.380 |
Why?
|
Health Status Indicators | 1 | 2016 | 966 | 0.360 |
Why?
|
Hemoglobins | 1 | 2016 | 1530 | 0.340 |
Why?
|
Influenza, Human | 1 | 2021 | 1539 | 0.330 |
Why?
|
Emergency Service, Hospital | 12 | 2024 | 7875 | 0.300 |
Why?
|
Resuscitation | 4 | 2022 | 679 | 0.300 |
Why?
|
Ubiquinone | 2 | 2021 | 181 | 0.300 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5891 | 0.300 |
Why?
|
Body Temperature Regulation | 2 | 2021 | 292 | 0.300 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2024 | 10383 | 0.290 |
Why?
|
Brain Diseases | 1 | 2016 | 1546 | 0.280 |
Why?
|
Retrospective Studies | 36 | 2024 | 81515 | 0.280 |
Why?
|
Multicenter Studies as Topic | 2 | 2024 | 1731 | 0.270 |
Why?
|
Anemia | 1 | 2016 | 1511 | 0.270 |
Why?
|
Oxygen | 2 | 2024 | 4241 | 0.260 |
Why?
|
Patient Transfer | 2 | 2024 | 790 | 0.260 |
Why?
|
Double-Blind Method | 7 | 2024 | 12437 | 0.250 |
Why?
|
Treatment Outcome | 18 | 2024 | 65189 | 0.250 |
Why?
|
Humans | 93 | 2024 | 765956 | 0.250 |
Why?
|
Hydrocortisone | 3 | 2024 | 1827 | 0.240 |
Why?
|
Middle Aged | 50 | 2024 | 223004 | 0.240 |
Why?
|
Nervous System Diseases | 4 | 2017 | 1660 | 0.240 |
Why?
|
Atropine | 3 | 2020 | 242 | 0.230 |
Why?
|
Intensive Care Units | 8 | 2021 | 3800 | 0.230 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2019 | 769 | 0.230 |
Why?
|
Pennsylvania | 5 | 2017 | 614 | 0.230 |
Why?
|
Community-Acquired Infections | 2 | 2019 | 470 | 0.230 |
Why?
|
Aged | 44 | 2024 | 171114 | 0.220 |
Why?
|
American Heart Association | 3 | 2023 | 1047 | 0.220 |
Why?
|
Vitamin B Complex | 3 | 2024 | 299 | 0.220 |
Why?
|
Thiamine Deficiency | 1 | 2024 | 48 | 0.210 |
Why?
|
Risk Assessment | 6 | 2018 | 24283 | 0.210 |
Why?
|
Hypotension | 3 | 2020 | 885 | 0.210 |
Why?
|
Male | 56 | 2024 | 363691 | 0.210 |
Why?
|
Survival Analysis | 9 | 2020 | 10070 | 0.200 |
Why?
|
Pyruvate Dehydrogenase Complex | 2 | 2024 | 63 | 0.200 |
Why?
|
Female | 58 | 2024 | 396101 | 0.200 |
Why?
|
Adrenal Cortex Hormones | 3 | 2020 | 1880 | 0.200 |
Why?
|
Propanolamines | 1 | 2022 | 163 | 0.190 |
Why?
|
Hospitalization | 7 | 2021 | 10808 | 0.180 |
Why?
|
Length of Stay | 3 | 2021 | 6485 | 0.180 |
Why?
|
Critical Illness | 6 | 2023 | 2744 | 0.180 |
Why?
|
Electric Countershock | 3 | 2023 | 534 | 0.180 |
Why?
|
Creatinine | 2 | 2023 | 1915 | 0.180 |
Why?
|
Pharmacological Phenomena | 1 | 2020 | 10 | 0.180 |
Why?
|
Rewarming | 1 | 2021 | 63 | 0.180 |
Why?
|
Emergency Medicine | 2 | 2021 | 1221 | 0.180 |
Why?
|
Adult | 33 | 2024 | 223038 | 0.180 |
Why?
|
Prospective Studies | 14 | 2024 | 54806 | 0.170 |
Why?
|
Partial Pressure | 2 | 2017 | 245 | 0.160 |
Why?
|
Prone Position | 1 | 2020 | 201 | 0.160 |
Why?
|
Neuromuscular Nondepolarizing Agents | 1 | 2020 | 144 | 0.160 |
Why?
|
Blood Circulation | 2 | 2017 | 248 | 0.160 |
Why?
|
Neuromuscular Blockade | 1 | 2020 | 146 | 0.160 |
Why?
|
Intubation, Intratracheal | 2 | 2017 | 1303 | 0.160 |
Why?
|
Vasoconstrictor Agents | 2 | 2022 | 655 | 0.160 |
Why?
|
Myocardial Infarction | 2 | 2016 | 11501 | 0.160 |
Why?
|
Alcoholism | 2 | 2021 | 1975 | 0.160 |
Why?
|
Time Factors | 11 | 2024 | 40065 | 0.150 |
Why?
|
Patient Positioning | 1 | 2020 | 328 | 0.150 |
Why?
|
Critical Care | 3 | 2019 | 2712 | 0.150 |
Why?
|
Multiple Organ Failure | 1 | 2020 | 390 | 0.140 |
Why?
|
Carbon Dioxide | 2 | 2023 | 1137 | 0.140 |
Why?
|
Pneumonia | 2 | 2019 | 2157 | 0.140 |
Why?
|
Resuscitation Orders | 1 | 2019 | 275 | 0.140 |
Why?
|
Efficiency, Organizational | 1 | 2021 | 697 | 0.140 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2021 | 624 | 0.140 |
Why?
|
Workload | 1 | 2022 | 851 | 0.130 |
Why?
|
Defibrillators | 1 | 2016 | 39 | 0.130 |
Why?
|
Ownership | 1 | 2019 | 338 | 0.130 |
Why?
|
Cytochromes c | 1 | 2017 | 173 | 0.130 |
Why?
|
Odds Ratio | 3 | 2019 | 9649 | 0.130 |
Why?
|
Pulmonary Gas Exchange | 1 | 2018 | 389 | 0.130 |
Why?
|
Comprehension | 1 | 2021 | 638 | 0.130 |
Why?
|
Blood Gas Analysis | 1 | 2017 | 380 | 0.130 |
Why?
|
Risk Management | 1 | 2019 | 559 | 0.130 |
Why?
|
Patients | 2 | 2019 | 910 | 0.120 |
Why?
|
Urban Health Services | 1 | 2016 | 176 | 0.120 |
Why?
|
Prognosis | 9 | 2021 | 29921 | 0.120 |
Why?
|
Needs Assessment | 2 | 2018 | 1138 | 0.120 |
Why?
|
Tidal Volume | 1 | 2017 | 519 | 0.120 |
Why?
|
Magnesium | 2 | 2019 | 813 | 0.120 |
Why?
|
Malpractice | 1 | 2019 | 561 | 0.110 |
Why?
|
Hyperoxia | 1 | 2016 | 260 | 0.110 |
Why?
|
Glycolysis | 1 | 2018 | 838 | 0.110 |
Why?
|
Narration | 1 | 2016 | 223 | 0.110 |
Why?
|
Kidney | 3 | 2024 | 7066 | 0.110 |
Why?
|
Reference Standards | 1 | 2017 | 1013 | 0.110 |
Why?
|
Organizational Policy | 1 | 2016 | 434 | 0.110 |
Why?
|
Aged, 80 and over | 12 | 2020 | 59488 | 0.110 |
Why?
|
Wakefulness | 1 | 2020 | 1282 | 0.110 |
Why?
|
Practice Guidelines as Topic | 4 | 2019 | 7425 | 0.110 |
Why?
|
Acute Disease | 1 | 2024 | 7232 | 0.110 |
Why?
|
United States | 14 | 2022 | 72898 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1084 | 0.100 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2017 | 622 | 0.100 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1275 | 0.100 |
Why?
|
Demography | 1 | 2016 | 1641 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2020 | 1387 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2024 | 3615 | 0.090 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 869 | 0.090 |
Why?
|
Leukocytes, Mononuclear | 1 | 2018 | 1857 | 0.090 |
Why?
|
Respiratory Insufficiency | 2 | 2017 | 1240 | 0.090 |
Why?
|
Survival Rate | 4 | 2021 | 12795 | 0.090 |
Why?
|
Firearms | 1 | 2018 | 630 | 0.090 |
Why?
|
Interleukins | 1 | 2016 | 791 | 0.090 |
Why?
|
Ultrasonography, Prenatal | 1 | 2019 | 1774 | 0.090 |
Why?
|
Patient Discharge | 4 | 2016 | 3461 | 0.090 |
Why?
|
Renal Insufficiency | 1 | 2016 | 804 | 0.090 |
Why?
|
Glucocorticoids | 1 | 2019 | 2132 | 0.090 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 1217 | 0.090 |
Why?
|
Internship and Residency | 2 | 2021 | 5946 | 0.080 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2015 | 645 | 0.080 |
Why?
|
Recovery of Function | 2 | 2017 | 2966 | 0.080 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2186 | 0.080 |
Why?
|
Quality Assurance, Health Care | 1 | 2019 | 2172 | 0.080 |
Why?
|
Cause of Death | 1 | 2019 | 3708 | 0.070 |
Why?
|
Inpatients | 1 | 2019 | 2564 | 0.070 |
Why?
|
Comorbidity | 3 | 2017 | 10563 | 0.070 |
Why?
|
Emergency Medical Services | 2 | 2016 | 1938 | 0.070 |
Why?
|
Hospitals, Pediatric | 3 | 2022 | 1846 | 0.070 |
Why?
|
Pandemics | 3 | 2022 | 8701 | 0.070 |
Why?
|
Cohort Studies | 6 | 2023 | 41647 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3229 | 0.070 |
Why?
|
Cerebrovascular Circulation | 1 | 2017 | 2673 | 0.070 |
Why?
|
Disease Management | 2 | 2014 | 2535 | 0.070 |
Why?
|
Lidocaine | 2 | 2020 | 550 | 0.070 |
Why?
|
Survivors | 4 | 2018 | 2372 | 0.060 |
Why?
|
Propensity Score | 3 | 2019 | 1968 | 0.060 |
Why?
|
Logistic Models | 5 | 2019 | 13266 | 0.060 |
Why?
|
Fever | 1 | 2012 | 1603 | 0.060 |
Why?
|
Philadelphia | 2 | 2016 | 267 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2019 | 2971 | 0.060 |
Why?
|
Coronary Angiography | 1 | 2016 | 4494 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 4348 | 0.060 |
Why?
|
Hospitals | 3 | 2023 | 3888 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10850 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2021 | 4873 | 0.060 |
Why?
|
Mitochondria | 1 | 2017 | 3673 | 0.050 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2014 | 1480 | 0.050 |
Why?
|
Models, Statistical | 1 | 2017 | 5089 | 0.050 |
Why?
|
Lactates | 1 | 2023 | 398 | 0.050 |
Why?
|
Predictive Value of Tests | 5 | 2018 | 15398 | 0.050 |
Why?
|
Ventricular Function, Left | 1 | 2015 | 3928 | 0.050 |
Why?
|
Hemodynamics | 3 | 2022 | 4183 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2014 | 3000 | 0.050 |
Why?
|
APACHE | 1 | 2021 | 268 | 0.040 |
Why?
|
Physicians | 1 | 2018 | 4588 | 0.040 |
Why?
|
Child | 7 | 2024 | 80563 | 0.040 |
Why?
|
Hypernatremia | 1 | 2020 | 78 | 0.040 |
Why?
|
Analgesics, Opioid | 1 | 2016 | 3835 | 0.040 |
Why?
|
Academic Medical Centers | 2 | 2024 | 2780 | 0.040 |
Why?
|
Tachycardia | 1 | 2022 | 594 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6309 | 0.040 |
Why?
|
Norepinephrine | 1 | 2022 | 900 | 0.040 |
Why?
|
Organizational Case Studies | 1 | 2019 | 299 | 0.040 |
Why?
|
Haloperidol | 1 | 2020 | 391 | 0.040 |
Why?
|
Anaerobiosis | 1 | 2018 | 140 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20125 | 0.040 |
Why?
|
Bicarbonates | 1 | 2019 | 293 | 0.040 |
Why?
|
Incidence | 4 | 2019 | 21480 | 0.040 |
Why?
|
Pregnancy, Ectopic | 1 | 2019 | 146 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14652 | 0.040 |
Why?
|
Risk Factors | 4 | 2017 | 74836 | 0.040 |
Why?
|
Vasopressins | 1 | 2019 | 359 | 0.040 |
Why?
|
Ribonuclease P | 1 | 2017 | 18 | 0.040 |
Why?
|
Amiodarone | 1 | 2019 | 216 | 0.030 |
Why?
|
Uremia | 1 | 2018 | 202 | 0.030 |
Why?
|
Knowledge | 1 | 2018 | 178 | 0.030 |
Why?
|
Respiratory Rate | 1 | 2018 | 179 | 0.030 |
Why?
|
Heart Function Tests | 1 | 2017 | 317 | 0.030 |
Why?
|
Vital Signs | 1 | 2017 | 147 | 0.030 |
Why?
|
Adolescent | 6 | 2021 | 88832 | 0.030 |
Why?
|
Confusion | 1 | 2018 | 277 | 0.030 |
Why?
|
Culture Media | 1 | 2018 | 890 | 0.030 |
Why?
|
Sex Factors | 2 | 2021 | 10602 | 0.030 |
Why?
|
Preoperative Period | 1 | 2018 | 566 | 0.030 |
Why?
|
Dexmedetomidine | 1 | 2020 | 316 | 0.030 |
Why?
|
Coronary Care Units | 1 | 2017 | 235 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2018 | 720 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2020 | 2229 | 0.030 |
Why?
|
Triage | 1 | 2022 | 996 | 0.030 |
Why?
|
Hospitals, Urban | 1 | 2017 | 493 | 0.030 |
Why?
|
Epinephrine | 1 | 2019 | 783 | 0.030 |
Why?
|
Glasgow Coma Scale | 1 | 2017 | 575 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39194 | 0.030 |
Why?
|
California | 1 | 2019 | 1436 | 0.030 |
Why?
|
Life Support Systems | 1 | 2014 | 11 | 0.030 |
Why?
|
Physicians, Women | 1 | 2021 | 512 | 0.030 |
Why?
|
Pregnancy Trimester, First | 1 | 2019 | 920 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2652 | 0.030 |
Why?
|
Safety | 1 | 2018 | 1157 | 0.030 |
Why?
|
Area Under Curve | 1 | 2018 | 1638 | 0.030 |
Why?
|
Echocardiography | 2 | 2017 | 5045 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2019 | 26349 | 0.030 |
Why?
|
Age Distribution | 1 | 2019 | 2858 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2077 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1816 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15880 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 2017 | 1158 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2017 | 1187 | 0.030 |
Why?
|
Hypnotics and Sedatives | 1 | 2020 | 1191 | 0.020 |
Why?
|
Viral Load | 1 | 2021 | 3386 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2020 | 1393 | 0.020 |
Why?
|
Infant | 3 | 2019 | 36385 | 0.020 |
Why?
|
Cross Infection | 1 | 2020 | 1427 | 0.020 |
Why?
|
Child, Preschool | 3 | 2019 | 42500 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3432 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2020 | 7478 | 0.020 |
Why?
|
Ultrasonography | 1 | 2024 | 5993 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2017 | 2352 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2018 | 1792 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3850 | 0.020 |
Why?
|
Young Adult | 3 | 2022 | 59886 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3620 | 0.020 |
Why?
|
Pregnancy | 2 | 2024 | 30258 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2012 | 912 | 0.020 |
Why?
|
Syndrome | 1 | 2015 | 3271 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2019 | 2115 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2014 | 2910 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2021 | 3426 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26313 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2019 | 2243 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5746 | 0.020 |
Why?
|
Qualitative Research | 1 | 2019 | 3138 | 0.020 |
Why?
|
Algorithms | 2 | 2022 | 14071 | 0.020 |
Why?
|
Information Dissemination | 1 | 2016 | 1142 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22340 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1884 | 0.020 |
Why?
|
Glucose | 1 | 2019 | 4335 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9338 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 2418 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2020 | 3074 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10729 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2018 | 3564 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12509 | 0.020 |
Why?
|
Calcium | 1 | 2019 | 5767 | 0.020 |
Why?
|
Curriculum | 1 | 2019 | 3782 | 0.020 |
Why?
|
Lung | 1 | 2024 | 10033 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7836 | 0.020 |
Why?
|
Heart Rate | 1 | 2016 | 4203 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9591 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8501 | 0.010 |
Why?
|
Quality Improvement | 1 | 2019 | 3853 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8733 | 0.010 |
Why?
|
Societies, Medical | 1 | 2016 | 3956 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 2686 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10429 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9443 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8611 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 8067 | 0.010 |
Why?
|
Pain | 1 | 2016 | 5077 | 0.010 |
Why?
|
Animals | 1 | 2024 | 168759 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21056 | 0.010 |
Why?
|